Drug intelligence / Profile preview

Bioeffective A

Development stage
Preclinical
Lead developer
Prenolica
Administration
Oral, Topical
01

Overview

**Bioeffective A** is a proprietary, multi-constituent conifer green needle extract developed by Solagran, now Prenolica. Also called **Conifer Green Needle Complex**, it is produced from green conifer needles through a proprietary extraction process and contains a broad mixture of naturally occurring constituents, including chlorophyll-related compounds, carotenoids, polyprenols, phytosterols, fatty acids, resin acids, vitamins, and minerals. It is marketed primarily as an oral antioxidant and general-wellbeing complementary medicine/nutraceutical, with topical formulations also marketed for skin and wound-support applications. Its activity is not attributable to a single defined molecular target; reported biological effects include antioxidant, antibacterial, antifungal, and tissue-repair-related activity. A published observational pilot study evaluated Conifer Green Needle Complex in patients with precancerous gastric lesions, but Bioeffective A is not an INN-designated pharmaceutical drug or a conventional target-defined therapeutic.

Brand names
Taiga Professional A320NuvaPine ABioeffective Gel
Other names
Conifer Green Needle ComplexCGNC

Beyond the preview

Go deeper on Bioeffective A.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bioeffective A.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call